Oxbryta (Voxelotor) is a medication approved by the FDA in December 2019 to treat sickle cell disease in children and adults. Recent studies have indicated that Oxbryta is associated with increased VOCs, organ damage, and a higher risk of death in patients who use it. The FDA has issued a warning to patients to immediately stop using Oxbryta, and, in September 2024, Pfizer pulled the drug from the market worldwide.

If you or someone you know has been prescribed Oxbryta and suffered kidney failure, stroke, or death, contact Law Offices of Gary Green at 1-888-442-7947 or ggreen@gGreen.com .

Our creed
Our creed

Our promise to our clients & the
communities we serve

Office location
Office location

in Arkansas

Employment opportunities
Employment opportunities

at Law Offices of Gary Green